StemCell Therapy

LOS ANGELES, April 09, 2020 (GLOBE NEWSWIRE) -- Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer,announces that all three submissions to the 23rd Annual Meeting of the ASCGT were accepted for presentation. The Conference will be held virtually May 12-15, 2020.

Dr. Serhat Gumruku, inventor and co-founder, will have two presentations: Hijacking HBV Pol to Induce Apoptosis Specifically in Infected HepatocytesIn Vivo: A Novel Approach for Potential Treatment or Cure; and Increased Engraftment of Gene Modified HSPCs Overexpressing ALDH1 UsingIn VivoChemoselection. Dr. Ramesh Halder, Senior Staff Scientist, will present: Gene Modified CD34+Cells With Increased ALDH1 Expression ConfersIn VitroProtection Against Cyclophosphamide.

Forward-Looking StatementsStatements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as believes, plans, expects, aims, intends potential, or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Enochians most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Enochian undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

Contact: ir@enochianbio.com

More here:
Enochian Biosciences Announces Scientific Presentations at the American Society of Cell and Gene Therapy (ASCGT) Annual Meeting - Yahoo Finance

This entry was posted on April 11, 2020 at 3:54 am and is filed under Gene therapy. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |